Question and Answer Section - February 2008

William Brown and Margareth Marques
The following questions have been submitted by readers of Dissolution Technologies. Margareth Marques, Ph. D. and Will Brown, United States Phamacopeia, authored responses to each of the questions.
*Note: These are opinions and interpretations of the authors, and are not necessarily the official viewpoints of the USP

Email for correspondence: web@usp.org

Q Why can differences be observed between dissolution profiles obtained with water and pH 6.8 phosphate buffer if the pH of both media is almost the same?
A It is advisable to measure the pH of the water immediately before using it. Do not assume that the pH is always going to be around 6.8. The pH of water can vary according to the purification process, when it was obtained, if it was degassed or not, the length of time it was stored, and so forth. Also keep in mind that water has negligible buffering capacity. During the dissolution process, depending on the characteristics of the drug substance and the formulation, the pH of the medium can reach a value where the drug substance is poorly soluble, and this is going to decrease the release rate or even stop it. Water is not generally considered a biorelevant medium. For the reasons stated, the use of water as a dissolution medium is discouraged.

Q It was observed during a development project that the dissolution profile was dependent on the ionic strength of the medium. Is there any preferred ionic strength enforced by regulatory agencies such as FDA or EMEA?
A No, you are going to use the dissolution medium with the ionic strength that is the most discriminative for your formulation and that does not interfere with the release mechanism or with the quantitative step of the dissolution test. It is advisable to work with ionic strengths as close as to the biological ones as possible to have more biorelevant media.

Q Is there any suitable sinker to use when doing disintegration testing of hard gelatin capsules to avoid the flotation of these dosage forms?
A Please refer to the USP General Chapter <701> Disintegration, under Procedure, Hard Gelatin Capsules. In this situation, a removable wire cloth that has a plain square weave with 1.8- to 2.2-mm mesh apertures and with a wire diameter of 0.60�0.655 mm can be attached to the surface of the upper plate of the basket-rack assembly. The wire mesh will prevent the capsule from floating out of its tube. Furthermore, the General Chapter has been revised to state that at no time should the top of the basket rack assembly become submerged thus preventing escape of capsules during testing. Although their use is not favored, disks can be used to limit the tendency of a capsule to float.

Q For the preparation of simulated gastric fluid according to the USP, can one rely on the information stated on the label of the pepsin to be used?
A The description of Simulated Gastric Fluid TS in the Reagents section of USP says to use 3.2 g of purified pepsin that has specific qualities. Those qualities are that it is derived from porcine stomach mucosa and that it has an activity of 800�2500 units per mg as determined by the test in the Food Chemical Codex (FCC). The FCC test uses the reduction in volume of egg albumin with time and compares the sample with the USP Reference Standard. Enzymatic activity depends on several conditions such as pH, temperature, substrate, and so forth. Therefore, enzymatic activity determined using differing substrates and conditions cannot be easily compared. The activity of the pepsin should be determined according to the USP requirements to demonstrate its acceptability for use in preparing the Test solution. The claim on the label of the reagent may not reflect this. The enzymatic activity of pepsin should be determined just before use. Any degradation it may have undergone should also be considered.

Q When the quantitative step of the dissolution test is by UV absorption, should the use of pepsin in the preparation of simulated gastric fluid be avoided because pepsin might introduce a high UV background? Can this problem be avoided by using HPLC with a UV detector?
A Pepsin contains aromatic amino acid residues that contribute to the background absorbance of dissolution samples. While this will tend to decrease the absorbance range available, the absorbance due to the enzyme in the sample and in the blank will be equal, allowing the absorbance of the analyte to be measured. Therefore, the UV analysis may still be practicable. It is not clear that this type of sample would be better analyzed using HPLC with UV detection, but because of the separation mechanism involved, the possible interference due to the enzyme could be reduced or eliminated.

Q Can the f1 and f2 equations employed to compare dissolution profiles be used to compare intrinsic dissolution rates?
A Typically, an intrinsic dissolution measurement is made on a pure drug substance. The usual methods involve evaluating the dissolution rate from a sample provided that a constant surface area is maintained. For those methods, the intrinsic dissolution rate is calculated from the slope of the curve concentration versus time, but only while this relationship is linear. The comparison between two such curves can be as simple as the ratio of the slopes of their linear portions. More information on the use of intrinsic dissolution to classify drugs can be obtained in the paper: Yu, L. X.; Carlin, A. S.; Amidon, G. L.; Hussain, A. S. Feasibility studies of utilizing disk intrinsic dissolution rate to classify drugs. Int. J. Pharm. 2004, 270 (1�2), 221�227.

Q When using dissolution medium containing large amounts of surfactant, how can foaming be avoided?
A To reduce or avoid the foaming, an antifoaming agent could be used. Its concentration should be as low as possible, and any interference in the quantitative step of the dissolution should be investigated. An example of a possible antifoaming agent is one or two drops of n-octanol in 10 L of dissolution medium. Any added component in the dissolution medium should be recorded and ultimately must be described in standard procedures.